NorthWest Biotherapeutics Inc (NWBO)

[flipper44]

I missed this/your post earlier. The survival for SOC at five years is 5% or less. Under the new definition for GBM, it could drop to 3% or less with current SOC. Tumor treating field proponents claim to raise 5 year survival to 12% or 13% (under the old definition), but they didn’t gather mature data to prove it (even ex agrees with this). They extrapolated highly censored data. Garbage in garbage out.

As far as your other point about “stalling out,” that’s water under the bridge. (Your cost analysis is way off, BTW. There were other interim grants.)